NCT06811376 Pilot Trial of Spiritual Care Interventions for Patients With Cancer
| NCT ID | NCT06811376 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Weill Medical College of Cornell University |
| Condition | Advanced Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2025-02-13 |
| Primary Completion | 2027-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2025-02-13 with a primary completion date of 2027-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a pilot trial of the effects of spiritual care interventions on spiritual well-being and readiness to engage in advance care planning (ACP) among black patients with advanced cancer recruited from outpatient settings to determine the feasibility of conducting a larger trial of effects of early integration of spiritual care into outpatient oncology care on patient outcomes.
Eligibility Criteria
Inclusion Criteria: 1. Diagnosed with a life-limiting, advanced cancer. 2. Identifies racially as black or African American. 3. Is fluent in English. Exclusion Criteria: 1. Have received medical system-based spiritual care within the past 2 months. 2. Have already completed a DNR order. 3. Are too weak or cognitively impaired to engage in study activities
Contact & Investigator
Paul K Maciejewski, Ph.D.
PRINCIPAL INVESTIGATOR
Weill Medical College of Cornell University
Frequently Asked Questions
Who can join the NCT06811376 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Advanced Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06811376 currently recruiting?
Yes, NCT06811376 is actively recruiting participants. Contact the research team at mkp4005@med.cornell.edu for enrollment information.
Where is the NCT06811376 trial being conducted?
This trial is being conducted at Brooklyn, United States, Galveston, United States.
Who is sponsoring the NCT06811376 clinical trial?
NCT06811376 is sponsored by Weill Medical College of Cornell University. The principal investigator is Paul K Maciejewski, Ph.D. at Weill Medical College of Cornell University. The trial plans to enroll 64 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.